Some of the Canadian cannabis stocks on our list are down as much as 26% during the past month
SmallCapPower | March 23, 2017: Marijuana stocks in Canada have been in a downtrend during the past few weeks, with big names in the industry being investigated for banned pesticide use as well as the Canadian government’s caution in taking their time to legalize recreational marijuana. Having said that, the Canadian cannabis stocks on our list today are expanding production and providing updates on construction of their growing facilities in the near term. This impending news may be the catalyst required for a rebound in the budding Canadian marijuana space.
Canopy Growth Corp. (TSX: WEED) – $9.85
Pharmaceuticals
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. Tweed is a licensed producer of medical marijuana. Tweed’s commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year.
- Market Cap: $1,174.8 million
- Revenue (LTM): $22.90 million
- Month-to-Date Price Change: -17.0%
- EV / Sales: 11.9x
Aurora Cannabis Inc. (TSXV: ACB) – $2.25
Pharmaceuticals
Aurora Cannabis Inc. is engaged in the production and sale of medical cannabis. The Company’s product types include Tetrahydrocannabinol (THC), Cannabidiole (CBD), indica, sativa and hybrid. Its product range includes BLACK TUSK 2, CHESTER, KAINE and TOWER. The THC product is responsible for the felt from cannabis and is connected to the immune system regulating, anti-inflammatory and pain relieving properties of medical marijuana.
- Market Cap: $534.4 million
- Revenue (LTM): $5.5 million
- Month-to-Date Price Change: -11.8%
- EV / Sales: 14.4x
Aphria Inc. (TSX: APH) – $6.35
Pharmaceuticals
Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company’s retail sales are sold primarily through the Company’s online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois.
- Market Cap: $592.6 million
- Revenue (LTM): $11.50 million
- Month-to-Date Price Change: -5.9%
- EV / Sales: 16.4x
OrganiGram Holdings Inc. (TSXV: OGI) – $2.16
Pharmaceuticals
OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc. is a licensed medical marijuana producer as regulated by Health Canada under the Marihuana Medical Access Regulations (MMAR) of the Government of Canada.
- Market Cap: $163.7 million
- Revenue (LTM): $6.4 million
- Month-to-Date Price Change: -13.6%
- EV / Sales: 7.5x
Supreme Pharmaceuticals Inc. (CSE: SL) – $1.25
Pharmaceuticals
Supreme Pharmaceuticals Inc. is a Canada-based development-stage company focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario.
- Market Cap: $144.9 million
- Revenue (LTM): $0
- Month-to-Date Price Change: -26.0%
- EV / Sales: n/a
